Vaccinated patients have reduced rates of hospitalization after receiving casirivimab and imdevimab for COVID-19
| Autor: | Tony Zitek, Tarang Kheradia, Michael T Dalley, Ryan Napolillo, David A. Farcy, Kathleen Jodoin, Faith Quenzer |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19) business.industry medicine.drug_class SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Vaccination COVID-19 General Medicine Monoclonal antibody Antibodies Monoclonal Humanized Virology Article Hospitalization Casirivimab/imdevimab Emergency Medicine Medicine Humans Monoclonal antibodies business |
| Zdroj: | The American Journal of Emergency Medicine |
| ISSN: | 1532-8171 0735-6757 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect